We are accepting clients who worked, lived, or served in the military at Marine Corps Base Camp Lejeune in Jacksonville, North Carolina, and have been diagnosed with a related injury. The water on the base was contaminated with toxic chemicals, which caused many of those present on the base to develop severe illnesses, including cancer and other serious health conditions. Those chemicals included volatile organic compounds (VOCs) such as industrial solvents perchloroethylene (PCE), trichloroethylene (TCE), vinyl chloride, and benzene.
Members of the Camp Lejeune community on the base were exposed to the contaminated water between August 1, 1953, and December 31, 1987. The subsequent lawsuits have accused the federal government of knowingly supplying drinking water contaminated with toxic chemicals to the base.
Under the Camp Lejeune Justice Act of 2022, which was signed into law by President Biden on August 10, 2022, clients can seek compensation for their injuries, including pain and suffering and medical expenses related to diagnosis and treatment. The new law opens a new window of time to file a claim, which is two years from the date the Camp Lejeune Justice Act was enacted. Even veterans denied disability by the Veterans Administration may qualify for compensation.
Potential clients are veterans and members of the community who worked, lived, served in the military, or were otherwise present at Marine Corps Base Camp Lejeune in Jacksonville, North Carolina, and suffered injuries after being exposed to the contaminated water. Clients must have spent at least 30 cumulative days at Camp Lejeune between August 1, 1953, and December 31, 1987. Illnesses associated with exposure to the chemicals found in the Camp Lejeune drinking water include cancers and other serious diseases including bladder cancer, kidney cancer, leukemia, liver cancer, myelodysplastic syndromes, multiple myeloma, Hodgkin’s and Non-Hodgkin’s Lymphoma, fatty liver disease (hepatic steatosis), female Infertility, miscarriage, Parkinson’s disease, renal toxicity, and scleroderma.